After decades of limited research and legal roadblocks to medical and recreational use, psychedelic drugs are rapidly remerging as treatments of interest in psychiatry. We interviewed two experts in the field.
COVID-19 has caused disruptions all across the world. In this piece, we take a look at what working during the pandemic has been like for psychiatric residents, as well as opportunities that the current situation has offered for learning.
Maintaining a consistent sleep-wake schedule, including exposure to bright light in the morning and avoidance of it at night, may be the most reliable way to reduce pandemic-induced sleep problems.
To dig deeper into the study and its importance for a growing field, we spoke with Laura H. Goldstein, PhD, of the Department of Psychology, King’s College London, United Kingdom.
We recently interviewed Jamieson Webster, PhD, and Victoria Malkin, PhD, LP, psychoanalysts based in New York who recently spent time on the frontlines of the COVID-19 pandemic in a Brooklyn hospital.
For psychiatric professionals, Administrations of Lunacy offers a critical exploration of psychiatry’s historic links to key moments in American history by focusing on an asylum that was the largest in the world in the mid-20th century.
In light of the COVID-19 pandemic, Psychiatry Advisor is making an effort to speak with providers from all professional backgrounds to gain insight into the field’s response to the current crisis.
Public health interventions and activity restrictions may act as barriers to mental health treatment, especially as emergency departments.
The AMA called for alterations for insurers, including terminating cost-sharing and prior authorization for chronic pain and OUD medications and removing restrictions on Medicaid preferred drug lists.
A study of Chinese healthcare workers may foreshadow the mental health burden placed upon physicians, nurses, and other professionals as COVID-19 strains the medical system in the United States.
